Pathology findings in preterm placentas of women with autoantibodies: a case-control study.

OBJECTIVE: To evaluate the placental histopathology findings in women with systemic lupus erythematosus or antiphospholipid syndrome delivered preterm. METHODS: We performed a case-control study comparing clinical outcomes and placental histopathology of 18 consecutive singleton pregnancies with systemic lupus erythematosus (n = 9) or antiphospholipid syndrome (n = 9) delivered between 24 and 37 weeks, and 54 controls matched for gestational age and type of preterm delivery (spontaneous or indicated). Placental examinations were performed by a single pathologist, and placental lesions were grouped into four categories: uteroplacental vascular pathology and related villous lesions; coagulation-related damage; chronic inflammation; and acute inflammatory lesions. Statistical analysis included the Mantel-Haenzsel or Fisher's exact test, and logistic regression, with a value of p < 0.05 or an odds ratio (OR) with 95% confidence intervals (Cl) not inclusive of unity considered significant. RESULTS: Lupus anticoagulant was positive in ten out of 18 cases and medium or high positive IgG anticardiolipin antibodies in seven out of 18. Antenatal treatment included corticosteroids (n = 9), low-dose aspirin (n = 15) and heparin (n = 8). Rates of necrotizing enterocolitis (33% vs. 0%, p < 0.001) and of perinatal mortality (33% vs. 9%, p = 0.02) were significantly different between cases and controls, and rates of birth weight < 10th centile approached statistical significance. Uteroplacental vascular lesions (OR 3.7, 95% CI 1.1, 11.7) and coagulation-related damage (OR 16.8, 95% CI 3.9, 72.6) were significantly more common among cases than controls, and rates of chronic inflammatory lesions approached significance. CONCLUSIONS: Cases of systemic lupus erythematosus and antiphospholipid syndrome delivered preterm are associated with a significant increase in placental vascular and coagulation-related lesions, which are reflected clinically by higher rates of perinatal mortality, necrotizing enterocolitis, and small-for-gestational age neonates.

[Risk factors and neonatal outcomes in shoulder dystocia]. / Fattori di rischio ed esiti neonatali della distocia di spalle.

BACKGROUND: Shoulder dystocia (SD) is a rare obstetrical complication but linked with a high perinatal morbidity and mortality rate. SD has been associated to a series of maternal and fetal risk factors due to a multifactorial etiology. This study analyzes the incidence of SD, its morbidity and associated risk factors. METHODS: Cases of SD occurred at the St. Gerardo Hospital (Monza) between January 1992 trough December 1997 have been retrospectively reviewed. Obstetrical and feto-neonatal data regarding cases of SD were compared to data regarding all the cephalic vaginal deliveries occurred in the same period in our Center. RESULTS: A total of 14,157 cephalic vaginal deliveries were included in this study, of these 21 infants (0.15%) had SD. A significantly higher incidence of SD cases was found in fetal macrosomia, maternal diabetes, induction of labor by PGE2, use of obstetrical vacuum, length of first stage of labor > 4 hours in multiparas and > 8 hours in nulliparas, and length of second stage > 60 minutes, regardless of parity. A closed association was also observed between SD and birth trauma as brachial plexus injury and humerus fracture. CONCLUSION: The incidence of SD in our population (0.15%) is below the average reported in the literature (0.37-1.1%). The well-known risk factors, whose low positive predictive value can nevertheless modify obstetrical management, are confirmed.

[Treatment of maternal hyperthyroidism and fetal goiter]. / Trattamento dell'ipertiroidismo materno e gozzo fetale.

A fetal goitre is a potentially dangerous phenomenon because of mechanical obstruction and possible fetal thyroid function disorders. During pregnancy women with a history of Graves' disease under treatment with propylthiouracil (PTU) have an increased risk for fetal goitre. In this report a patient with Graves' disease diagnosed in early pregnancy and treated with PTU which resulted in a fetal goitre is described. The fetal thyroid status, investigated by percutaneous fetal umbilical cord blood sampling, was normal and the reduction of PTU dosage was sufficient to decrease goitre volume.

Allelic expression of p73 in human ovarian cancers.

BACKGROUND: The p73 gene is structurally related to the tumor suppressor gene p53. The role of p73 in tumor development is still unclear and no data on ovarian cancer are so far available. For this reason we have analyzed, in a panel of ovarian cancers, the allelic distribution and expression of p73. PATIENTS AND METHODS: Fifty-one samples from ovarian cancers and five human ovarian cancer cell lines growing in culture were analyzed. Allelic origin was analyzed by PCR after digestion with the restriction enzyme Sty I. Heterozygous, informative cases were selected for studies aimed at evaluating allelic expression of p73. RESULTS: We found an allelic distribution similar to that previously reported. LOH was found in two patients with ovarian cancer. In one case in which normal ovarian tissue was available biallelic expression of p73 was found. CONCLUSION: In comparisons of ovarian cancers and borderline tumors, no differences in allelic distribution and/or expression were found, suggesting that p73 does not play an important role in the pathogenesis and development of ovarian cancer.